Mitochondrial complex I deficiency stratifies idiopathic Parkinson's disease

Area of Science:

• Neuroscience
• Mitochondrial Biology
• Genetics

Background:

• Idiopathic Parkinson's disease (iPD) is recognized for its complex and heterogeneous nature.
• Previous research has not identified distinct molecular subtypes of iPD.
• Understanding iPD heterogeneity is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate whether iPD can be stratified into molecular subtypes.
• To identify distinct clinical and molecular profiles associated with these subtypes.
• To explore the role of mitochondrial dysfunction in iPD pathogenesis.

Main Methods:

• Stratification of iPD patients based on neuronal respiratory complex I (CI) deficiency severity.
• Analysis of gene expression profiles in a cell type-specific manner.
• Quantification of neuronal mitochondrial DNA (mtDNA) deletions.
• Correlation of molecular findings with clinical phenotypes, including motor dominance.

Main Results:

• Two distinct iPD subtypes were identified: CI-deficient (CI-PD) and non-CI-deficient (nCI-PD).
• The CI-PD subtype (approx. 25% of cases) exhibits widespread neuronal CI deficiency, unique gene expression patterns, increased mtDNA deletions, and non-tremor dominant motor features.
• The nCI-PD subtype shows mitochondrial impairment limited to the substantia nigra and a tremor-dominant phenotype.

Conclusions:

• Neuronal CI deficiency serves as a key biomarker for stratifying iPD into distinct molecular subtypes.
• These subtypes possess unique molecular characteristics and clinical presentations.
• This stratification advances the understanding of iPD heterogeneity and has implications for future treatment strategies.